Unusually High Affinity of the PLK Inhibitors RO3280 and GSK461364 to HSA and Its Possible Pharmacokinetic Implications

Mol Pharm. 2023 Mar 6;20(3):1631-1642. doi: 10.1021/acs.molpharmaceut.2c00849. Epub 2023 Feb 22.

Abstract

The binding processes of two Polo-like kinase inhibitors, RO3280 and GSK461364, to the human serum albumin (HSA) protein as well as the protonation equilibria of both compounds have been studied combining absorbance and fluorescence spectroscopy experiments together with density functional theory calculations. We found that the charge states of RO3280 and GSK461364 are +2 and +1, respectively, at the physiological pH. Nevertheless, RO3280 binds to HSA in the charge state +1 prior to a deprotonation pre-equilibrium. Binding constants to site I of HSA of 2.23 × 106 and 8.80 × 104 M-1 were determined for RO3280 and GSK461364, respectively, at 310 K. The binding processes of RO3280 and GSK461364 to HSA are entropy- and enthalpy-driven, respectively. The positive enthalpy found for the RO3280-HSA complex formation could be related to a proton pre-equilibrium of RO3280.

Keywords: GSK461364; RO3280; drug−protein binding; fluorescence spectroscopy; human serum albumin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Humans
  • Protein Binding
  • Serum Albumin* / metabolism
  • Serum Albumin, Human* / metabolism
  • Spectrometry, Fluorescence
  • Thermodynamics

Substances

  • Serum Albumin
  • RO3280
  • GSK 461364
  • Serum Albumin, Human